Archive for the "Litigation" Category

What’s Your Evidence? The Danger of Hearsay Evidence in IP Litigation

Posted by Andrew Dixon on July 27th, 2016

In Pfizer Canada Inc. v. Teva Canada Limited, 2016 FCA 161, the Federal Court of Appeal (“FCA”) recently overturned a substantial damages award in a pharmaceutical patented medicines action on the basis that the trial judge admitted improper hearsay evidence. This is an important reminder that the hearsay rule of evidence is alive and well. [...]

TwitterFacebookLinkedInInstapaperShare
View the full post »